Financials Optiscan Imaging Limited
Equities
OIL
AU000000OIL4
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.089 AUD | +4.71% | +8.54% | +5.95% |
Mar. 21 | Optiscan Imaging Receives More Than AU$670,000 as R&D Tax Rebate | MT |
Feb. 22 | Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 28.12 | 27.27 | 17.68 | 141.7 | 68.13 | 50.1 |
Enterprise Value (EV) 1 | 26.56 | 25.72 | 18.31 | 134 | 64.15 | 49.64 |
P/E ratio | -13.3 x | -10.7 x | -9.94 x | -61.8 x | -16.1 x | -11.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 12.9 x | 20.6 x | 9.34 x | 63 x | 30.3 x | 19.1 x |
EV / Revenue | 12.2 x | 19.5 x | 9.67 x | 59.6 x | 28.5 x | 19 x |
EV / EBITDA | -9.85 x | -12.3 x | -11.3 x | -58.8 x | -15.5 x | -12 x |
EV / FCF | -11 x | -56.3 x | -21.6 x | -83.3 x | -26.6 x | -27 x |
FCF Yield | -9.08% | -1.78% | -4.64% | -1.2% | -3.77% | -3.71% |
Price to Book | 8.78 x | 9.66 x | 11.4 x | 13.9 x | 10.3 x | 16.5 x |
Nbr of stocks (in thousands) | 432,679 | 470,179 | 477,779 | 616,261 | 619,406 | 626,306 |
Reference price 2 | 0.0650 | 0.0580 | 0.0370 | 0.2300 | 0.1100 | 0.0800 |
Announcement Date | 8/31/18 | 8/30/19 | 8/31/20 | 8/29/21 | 8/31/22 | 8/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.186 | 1.322 | 1.893 | 2.249 | 2.249 | 2.618 |
EBITDA 1 | -2.698 | -2.097 | -1.615 | -2.277 | -4.144 | -4.133 |
EBIT 1 | -2.787 | -2.219 | -1.705 | -2.363 | -4.232 | -4.35 |
Operating Margin | -127.5% | -167.83% | -90.05% | -105.08% | -188.17% | -166.18% |
Earnings before Tax (EBT) 1 | -2.035 | -2.344 | -1.765 | -2.127 | -4.233 | -4.352 |
Net income 1 | -2.035 | -2.344 | -1.765 | -2.127 | -4.233 | -4.352 |
Net margin | -93.13% | -177.3% | -93.25% | -94.57% | -188.22% | -166.22% |
EPS 2 | -0.004905 | -0.005404 | -0.003721 | -0.003721 | -0.006844 | -0.007000 |
Free Cash Flow 1 | -2.412 | -0.4566 | -0.8492 | -1.608 | -2.416 | -1.841 |
FCF margin | -110.37% | -34.54% | -44.86% | -71.52% | -107.41% | -70.31% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/31/18 | 8/30/19 | 8/31/20 | 8/29/21 | 8/31/22 | 8/30/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 0.63 | - | - | - |
Net Cash position 1 | 1.56 | 1.55 | - | 7.77 | 3.98 | 0.46 |
Leverage (Debt/EBITDA) | - | - | -0.3899 x | - | - | - |
Free Cash Flow 1 | -2.41 | -0.46 | -0.85 | -1.61 | -2.42 | -1.84 |
ROE (net income / shareholders' equity) | -83.6% | -77.8% | -80.8% | -36.2% | -50.4% | -90.3% |
ROA (Net income/ Total Assets) | -51.2% | -35.7% | -30.1% | -19.5% | -26.9% | -43% |
Assets 1 | 3.972 | 6.571 | 5.873 | 10.9 | 15.75 | 10.13 |
Book Value Per Share 2 | 0.0100 | 0.0100 | 0 | 0.0200 | 0.0100 | 0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0.0100 | 0.0100 | 0 |
Capex 1 | 0.29 | 0 | 0.02 | 0.03 | 0.12 | 0.13 |
Capex / Sales | 13.29% | 0.34% | 1.07% | 1.37% | 5.52% | 4.85% |
Announcement Date | 8/31/18 | 8/30/19 | 8/31/20 | 8/29/21 | 8/31/22 | 8/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+5.95% | 46.58M | |
+7.83% | 220B | |
+6.21% | 183B | |
+9.80% | 133B | |
+24.39% | 107B | |
-0.95% | 63.05B | |
+11.92% | 51.74B | |
+4.81% | 50.47B | |
-0.24% | 40.91B | |
+23.27% | 31.91B |
- Stock Market
- Equities
- OIL Stock
- Financials Optiscan Imaging Limited